medigraphic.com
Boletín Médico del Hospital Infantil de México

2013, Number 3

<< Back Next >>

Bol Med Hosp Infant Mex 2013; 70 (3)

Tachycardia-induced cardiomyopathy in children and adolescents

Velázquez-Rodríguez E, Rodríguez-Piña H, Pacheco-Bouthillier A, Deras-Mejía LM, Jiménez-Arteaga S, Martínez-Sánchez A, Yáñez-Gutiérrez L, David-Gómez F , Alva-Espinoza C

Language: Spanish
References: 58
Page: 234-247
PDF size: 1865.69 Kb.


ABSTRACT

Background. Idiopathic dilated cardiomyopathy is the most common form of cardiomyopathy in children; however, potentially reversible causes may occasionally be identified. Among these is a group of patients with symptoms of congestive heart failure and persistent tachycardia representing a form of nonfamilial acquired cardiomyopathy known as tachycardia-induced cardiomyopathy or tachycardiomyopathy. This is a reversible condition with effective treatment of tachycardia. These patients may be misdiagnosed, potentially leading to inappropriate treatment. Diagnosis is often late and always should be suspected in patients with congestive heart failure and unexplained persistent tachycardia.
Case reports. We describe six pediatric patients (mean age 12 +4 years old, range 6-16 years). Patients presented with clinical manifestations of congestive heart failure followed by dilated cardiomyopathy. Different mechanisms of persistent tachycardia were documented as the cause and total recovery of ventricular function was achieved after successful treatment of tachycardia by catheter ablation.
Conclusion. The recognition of tachycardia-induced cardiomyopathy in pediatric patients is important. Opportune diagnosis and effective treatment are necessary because tachycardia-induced cardiomyopathy is a reversible cause of heart failure.


REFERENCES

  1. Shinbane JS, Wood MA, Jensen DN, Ellebongen KA, Fitzpatrick AP, Sheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709-715.

  2. 2. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647-1655.

  3. 3. Towbin AJ, Lowe MA, Colan DS, Sleeper AL, Orav JE, Clunie S, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006;296:1867-1876.

  4. 4. Grenier M, Osganian SK, Cox GF, Towbin JA, Colan SD, Lurie PR, et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J 2000;139(2 Pt 3):S86-S95.

  5. 5. Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. J Pediatr 2001;138:644-648.

  6. 6. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-276.

  7. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-1816.

  8. 8. Kasper EK, Agema WR, Hutchins GM, Deckers JW, Hare JM, Baughman KL. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994;23:586-590.

  9. 9. Winum PF, Cayla G, Rubini M, Beck L, Messner-Pellenc P. A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine. Pacing Clin Electrophysiol 2009;32:942-944.

  10. Jeong YH, Choi KJ, Song JM, Hwang ES, Park KM, Nam GB, et al. Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy. Clin Cardiol 2008;31:172-178.

  11. Redfield MM, Kay GN, Jenkins LS, Mianulli M, Jensen DN, Ellenbogen KA. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc 2000;75:790-795.

  12. Fujino T, Yamashita T, Suzuki S, Sugiyma H, Sagara K, Sawada H, et al. Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy. Circ J 2007;71:936-940.

  13. Velázquez-Rodríguez E, Martínez-Enríquez A. Dilated cardiomyopathy induced by ectopic atrial tachycardia. Arch Inst Cardiol Mex 2000;70:292-300.

  14. Medi C, Kalman MJ, Haqqani H, Vohra KJ, Morton BJ, Sparks BP. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol 2009;53:1791-1797.

  15. Nakazato Y. Tachycardiomyopathy. Indian Pacing Electrophysiol J 2002;2:104-113.

  16. Liu S, Olsson SB. An unusual cause of tachycardiomyopathy: incessant atypical AV nodal reentrant tachycardia induced by 1:2 AV conduction. Europace 2001;3:241-246.

  17. Tulino D, Dattilo G, Tulino V, Marte F, Patanè S. A congenital form of junctional ectopic tachycardia. Int J Cardiol 2010;145:e54-56.

  18. Sánchez Fernández-Bernal C, Benito-Bartolomé F, Moreno F. Reversibility of tachycardia-induced cardiomyopathy after radiofrequency ablation of incessant supraventricular tachycardia in infants. Br Heart J 1995;74:332-333.

  19. De Giovanni JV, Dindar A, Griffith MJ, Edgar RA, Silove ED, Stumper O, et al. Recovery pattern of left ventricular dysfunction following radiofrequency ablation of incessant supraventricular tachycardia in infants and children. Heart 1998;79:588-592.

  20. Velázquez-Rodríguez E, Morales-Hernández JA, Solórzano-Zepeda F. Disfunción ventricular izquierda inducida por taquicardia: regresión postablación con catéter. Rev Mex Cardiol 1998;9:121-133.

  21. Vijgen J, Hill P, Biblo LA, Carlson MD. Tachycardia-induced cardiomyopathy secondary to right ventricular outflow tract ventricular tachycardia: improvement of left ventricular systolic function after radiofrequency catheter ablation of the arrhythmia. J Cardiovasc Electrophysiol 1997;8:445-450.

  22. Arya A, Haghjoo M, Davari P, Sadr-Ameli MA. Resolution of tachycardia-induced cardiomyopathy following ablation of verapamil-sensitive idiopathic left ventricular tachycardia. Pediatr Cardiol 2006;27:146-148.

  23. Chugh SS, Shen WK, Luria DM, Smith HC. First evidence of premature ventricular complex-induced cardiomyopathy: a potentially reversible cause of heart failure. J Cardiovasc Electrophysiol 2000;11:328-329.

  24. Kleinman CS, Nehgme RA. Cardiac arrhythmias in the human fetus. Pediatr Cardiol 2004;25:234-251.

  25. Strasburger JF, Cuneo BF, Michon MM, Gotteiner NL, Deal BJ, McGregor SN, et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 2004;27:375-379.

  26. Salerno CJ, Kertesz NJ, Friedman RA, Fenrich AL Jr. Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children <3 or >3 years of age. J Am Coll Cardiol 2004;43:438-444.

  27. Toyohara K, Fukuhara H, Yoshimoto J, Ozaki N, Nakamura Y. Electrophysiologic studies and radiofrequency catheter ablation of ectopic atrial tachycardia in children. Pediatr Cardiol 2011;32:40-46.

  28. Paul T, Bertram H, Bökenkamp R, Hausdorf G. Supraventricular tachycardia in infants, children and adolescents: diagnosis, and pharmacological and interventional therapy. Paediatr Drugs 2000;2:171-181.

  29. Von Bergen NH, Abu Rasheed H, Law IH. Transcatheter cryoablation with 3-D mapping of an atrial ectopic tachycardia in a pediatric patient with tachycardia induced heart failure. J Interv Card Electrophysiol 2007;18:273-279.

  30. Van Hare GR, Witherell CL, Lesh MD. Follow-up of radiofrequency catheter ablation in children: results in 100 consecutive patients. J Am Coll Cardiol 1994;23:1651-1659.

  31. Kugler JD, Danford DA, Deal BJ, Gillette PC, Perry JC, Silka MJ, et al. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med 1994;330:1481-1487.

  32. Coumel P, Cabrol C, Fabiato A, Gourgon R, Slama R. Tachycardie permanente par rythme réciproque. I. Preuves du diagnostic par stimulation auriculaire et ventriculaire. Arch Mal Coeur 1967;60:1830-1864.

  33. Critelli G, Gallagher JJ, Monda V, Coltorti F, Scherillo M, Rossi L. Anatomic and electrophysiologic substrate of the permanent form of junctional reciprocating tachycardia. J Am Coll Cardiol 1984;4:601-610.

  34. Lindinger A, Heisel A, von Bernuth G, Paul T, Ulmer H, Kienast W, et al. Permanent junctional re-entry tachycardia. A multicentre long-term follow-up study in infants, children and young adults. Eur Heart J 1998;19:936-942.

  35. Vaksmann G, D’Hoinne C, Lucet V, Guillaumont S, Lupoglazoff JM, Chantepie A, et al. Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome. Heart 2006;92:101-104.

  36. Noë P, Van Driel V, Wittkampf F, Sreeram N. Rapid recovery of cardiac function after catheter ablation of persistent junctional reciprocating tachycardia in children. Pacing Clin Electrophysiol 2002;25:191-194.

  37. Song MK, Baek JS, Kwon BS, Kim GB, Bae EJ, Noh CI, et al. Clinical spectrum and prognostic factors of pediatric ventricular tachycardia. Circ J 2010;74:1951-1958.

  38. Yasui K, Shibata T, Yokoyama U, Nishizawa T, Takigiku K, Sakon T, et al. Idiopathic sustained left ventricular tachycardia in pediatric patients. Pediatr Int 2001;43:42-47.

  39. Ohe T, Aihara N, Kamakura S, Kurita T, Shimizu W, Shimomura K. Long-term outcome of verapamil-sensitive sustained left ventricular tachycardia in patients without structural heart disease. J Am Coll Cardiol 1995;25:54-58.

  40. Singh B, Kaul U, Talwar KK, Wasir HS. Reversibility of “tachycardia induced cardiomyopathy” following the cure of idiopathic left ventricular tachycardia using radiofrequency energy. Pacing Clin Electrophysiol 1996;19:1391-1392.

  41. Benito-Bartolomé F, Sánchez Fernández-Bernal C. Reversibilidad de la miocardiopatía tras curación de la taquicardia ventricular incesante mediante ablación con radiofrecuencia en el lactante. An Pediatr (Barc) 2000;53:156-158.

  42. Zellner JL, Spinale FG, Eble DM, Hewett KW, Crawford FA Jr. Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. Circ Res 1991;69:590-600.

  43. Spinale FG, Zellner JL, Tomita M, Crawford FA, Zile MR. Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy. Circ Res 1991;69:1058-1067.

  44. Whipple GH, Sheffield LT, Woodman EG, Thoephilis C, Friedman S. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart. Proc New Engl Cardiovasc Soc 1962;20:39-40.

  45. Patel HJ, Pilla JJ, Polidori DJ, Pusca SV, Plappert TA, Sutton MS, et al. Ten weeks of rapid ventricular pacing creates a long-term model of left ventricular dysfunction. J Thorac Cardiovasc Surg 2000;119(4 Pt 1):834-841.

  46. Kajstura J, Zhang X, Liu Y, Szoke E, Cheng W, Olivetti G, et al. The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 1995;92:2306-2317.

  47. Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol 1996;19:95-106.

  48. Mukherjee R, Hewett KW, Spinale FG. Myocyte electrophysiological properties following the development of supraventricular tachycardia-induced cardiomyopathy J Mol Cell Cardiol. 1995;27:1333-1348.

  49. Khasnis A, Jongnarangsin K, Abela G, Veerareddy S, Reddy V, Thakur R. Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol 2005;28:710-721.

  50. Spinale FG, Holzgrefe HH, Mukherjee R, Arthur SR, Child MJ, Powell JR. LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy. Am J Physiol 1995;268 (2 Pt 2):H836-H847.

  51. Yamamoto K, Burnett JC Jr, Meyer LM, Sinclair L, Stevens TL, Redfield MM. Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model. Am J Physiol 1996;271(6 Pt 2):R1529-R1534.

  52. Tomita M, Spinale FG, Crawford FA, Zile MR. Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function. Circulation 1991;83:635-644.

  53. Moe GW, Grima EA, Howard RJ, Seth R, Armstrong PW. Left ventricular remodeling and disparate changes in contractility and relaxation during the development of and recovery from experimental heart failure. Cardiovasc Res 1994;28:66-71.

  54. Spinale FG, Tanaka R, Crawford FA, Zile MR. Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 1992;85:717-729.

  55. Horenstein MS, Saarel E, Dick M, Karpawich PP. Reversible symptomatic dilated cardiomyopathy in older children and young adolescents due to primary non-sinus supraventricular tachyarrhythmias. Pediatr Cardiol 2003;24:274-279.

  56. Walker NL, Cobbe SM, Birnie DH. Tachycardiomyopathy: a diagnosis not to be missed. Heart 2004;90:e7.

  57. Calò L, De Ruvo E, Sette A, Sciarra L, Scioli R, Sebastiani F, et al. Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications. J Cardiovasc Med (Hagerstown) 2007;8:138-143.

  58. Lishmanov A, Chockalingam P, Senthilkumar A, Chockalingam A. Tachycardia-induced cardiomyopathy: evaluation and therapeutic options. Congest Heart Fail 2010;16:122-126




2020     |     www.medigraphic.com